Fig 1: Gene expression and clinical significance in the TCGA. A, Box plots of UQCRQ mRNA expression (P-value = .0012). B, C, Overall survival (OS) and Post Progression Survival (PPS) of 876 gastric cancer patients according to the UQCRQ status by Kaplan-Meier Plotter database. D, Box plots of NDUFB7 mRNA expression (P-value = 1.0e-6). E, F, Overall survival (OS) and Post Progression Survival (PPS) of 876 gastric cancer patients according to the NDUFB7 status by Kaplan-Meier Plotter database. G, Box plots of UQCRC2 mRNA expression (P-value = .0064). H, I, Overall survival (OS) and Post Progression Survival (PPS)of 876 gastric cancer patients according to the UQCRC2 status by Kaplan-Meier Plotter database
Fig 2: The expression level of UQCRQ, NDUFB7 and UQCRC2 protein in GC and adjacent tissues
Fig 3: Correlation of UQCRQ, NDUFB7 and UQCRC2 expression with immune infiltration level in gastric cancer. The correlation of UQCRQ, NDUFB7 and UQCRC2 relative expression with tumour purity and gastric cancer infiltrating immune cells, like B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrophils and dendritic cells were presented
Supplier Page from Abcam for Anti-UQCRQ antibody